Most GIST (85%) are characterized by activating mutations in one of 2 receptor tyrosine kinases: (a) KIT (80%) and (b) platelet-derived growth factor receptor A (PDGFRA) (5%).21-23. This evidence concerns the gene NTRK1 and gastrointestinal stromal tumor.